awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26862841-F42CB96C-423B-49E5-8D33-FB7FF8E2CF5D
Q26862841-F42CB96C-423B-49E5-8D33-FB7FF8E2CF5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26862841-F42CB96C-423B-49E5-8D33-FB7FF8E2CF5D
Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer
P2860
Q26862841-F42CB96C-423B-49E5-8D33-FB7FF8E2CF5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26862841-F42CB96C-423B-49E5-8D33-FB7FF8E2CF5D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55532cfda3911414fe12617136c7533e74f906cf
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr